Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Early Phase I Study of the Safety and Preliminary Efficacy of Human Fetal Retinal Pigment
Epithelial(fRPE) Cells Subretinal Transplantation in Age-Related Macular Degeneration(AMD)
Patients
Phase:
Early Phase 1
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University